Modelling the interactions between herpes simplex virus type 2 and HIV: Implications for the HIV epidemic in southern India

Sexually Transmitted Infections

Volumn 87, Issue 1, 2011, Pages 22-27

  Foss, Anna M ^a   Vickerman, Peter T ^a   Mayaud, Philippe ^a   Weiss, Helen A ^a   Ramesh, B M ^b,c   Reza Paul, Sushena ^d   Washington, Reynold ^b,c,d   Blanchard, James ^c   Moses, Stephen ^c   Lowndes, Catherine M ^a,e   Alary, Michel ^f   Watts, Charlotte H ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARNATAKA HEALTH PROMOTION TRUST   (India)

^c UNIVERSITY OF MANITOBA   (Canada)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL THERAPY; ARTICLE; ATTRIBUTABLE RISK; CLINICAL TRIAL; EPIDEMIC; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; MIXED INFECTION; MODEL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; VIRUS INFECTIVITY;

EPIDEMICS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; INDIA; MODELS, STATISTICAL; PROSTITUTION; REGRESSION ANALYSIS; VIRUS SHEDDING;

EID: 78751649116     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2009.041699     Document Type: Article

References (46)

1. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28.
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004;11(Suppl 1):24A-35.
3. Celum C, Levine R, Weaver M, et al. Genital herpes and human immunodeficiency virus: double trouble. Bull WHO 2004;82:447-53. (Pubitemid 38828431)
4. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004;35:435-45. (Pubitemid 38420652)
5. Van de Perre P, Segondy M, Foulongne V, et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 2008;8:490-7. (Pubitemid 352005823)
6. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS 2007;21:589-98.
7. Zhu J, Koelle DM, Cao J, et al. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007;204:595-603. (Pubitemid 46457082)
8. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83.
9. Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.
10. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000;182:1090-6.
11. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002;16:2425-30.
12. LeGoff J, Weiss HA, Gresenguet G, et al. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS 2007;21:1569-78.
13. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:2109-19.
14. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008;358:1560-71.
15. Lisco A, Vanpouille C, Tchesnokov EP, et al. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues. Cell Host Microbe 2008;4:260-70.
16. Stapleton JT, Balfour HH Jr. Coinfection alters the playing field: herpesviruses induce acyclovir to inhibit HIV. Cell Host Microbe 2008;4:194-5.
17. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008;198:1804-8.
18. Delany S, Mayaud P, Clayton T, et al. Impact of HSV-2 suppressive therapy on genital and plasma HIV-1 RNA in HIV-1 and HSV-2-seropositive women not taking ART: a randomized, placebo-controlled trial in Johannesburg, South Africa. AIDS 2009;23:461-9.
19. Dunne EF, Whitehead S, Sternberg M, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr 2008;49:77-83.
20. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-9. (Pubitemid 46294611)
21. Paz-Bailey G, Sternberg M, Puren AJ, et al. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis 2009;200:1039-49.
22. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/ HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007;196:1500-8.
23. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362:427-39.
24. Hennessey KA, Giorgi JV, Kaplan AH, et al. AIDS onset at high CD4+ cell levels is associated with high HIV load. AIDS Res Hum Retroviruses 2000;16:103-7.
25. Mayaud P, Nagot N, Konate I, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect 2008;84:332-7.
26. Lingappa JR, Baeten JM, Wald A, et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010;375:824-33.
27. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008;3:e2230.
28. Baggaley RF, Griffin JT, Chapman R, et al. Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS 2009;23:1005-13.
29. Blower S, Ma L. Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis 2004;39(Suppl 5):S240-7.
30. Freeman EE, White RG, Bakker R, et al. Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine 2009;27:940-6.
31. Korenromp EL, Bakker R, De Vlas SJ, et al. Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? a simulation modeling study. Sex Transm Dis 2002;29:228-38.
32. Orroth KK, White RG, Korenromp EL, et al. Empirical observations underestimate the proportion of Human Immunodeficiency Virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results. Sex Transm Dis 2006;33:536-44.
33. White RG, Orroth KK, Korenromp EL, et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: a modeling study. J Acquir Immune Defic Syndr 2004;37:1500-13.
34. White RG, Freeman EE, Orroth KK, et al. Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa. Sex Transm Infect 2008;84(Suppl 2): ii12-8.
35. Foss AM, Vickerman PT, Chalabi Z, et al. Dynamic modelling of herpes simplex virus type 2 (HSV-2) transmission: issues in structural uncertainty. Bulletin of Mathematical Biology 2009;71:720-49.
36. Ramesh BM, Rajeswari NV, Sankangoudar S. Female commercial sex workers in Karnataka: a baseline survey, 2002. Bangalore and Dharwad: India-Canada Collaborative HIV/AIDS Project (ICHAP) and Population Research Centre, 2003.
37. NACO. National Baseline High Risk and Bridge Population Behavioural Surveillance Survey- Part -I (FSW and their clients). India: National AIDS Control Organisation (NACO), 2001. http://www.nacoonline.org/publication.htm.
38. Freeman EE, Orroth KK, White RG, et al. Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect 2007;83(Suppl 1):i17-24.
39. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008;22:2179-85.
40. Freeman EE, Orroth K, White R, et al. The proportion of new HIV infections attributable to HSV- 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect 2007.
41. Nagot N, Ouedraogo A, Konate I, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and Human Immunodeficiency Virus Type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008;198:241-9.
42. Mark KE, Wald A, Magaret AS, et al. Rapid Onset And Clearance Of Genital Hsv Reactivations In Immunocompetent Adults: The Virus Is Usually "on". 17th International Society For Sexually Transmitted Diseases Research. Seattle, Washington, USA, 2007. [Abstract O-030]. http://www.isstdr. org/index.php?id=97.
43. Paz-Bailey G, Ramaswamy M, Hawkes SJ, et al. Genital Herpes Simplex Virus Type 2: epidemiology and management options in the developing world. Sex Transm Infect 2007;83:16-22. (Pubitemid 46293800)
44. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52. (Pubitemid 34043015)
45. Mahiane SG, Legeai C, Taljaard D, et al. Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa. AIDS 2009;23:377-83.
46. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.